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Abstract
Background: Acetaldehyde associated with alcoholic beverages was recently classified as carcinogenic (Group 1) to
humans based on uniform epidemiological and biochemical evidence. ALDH2 (aldehyde dehydrogenase 2) deficient
alcohol consumers are exposed to high concentrations of salivary acetaldehyde and have an increased risk of upper
digestive tract cancer. However, this interaction is not seen among ALDH2 deficient non-drinkers or rare drinkers,
regardless of their smoking status or consumption of edibles containing ethanol or acetaldehyde. Therefore, the aim
of this study was to examine the effect of the ALDH2 genotype on the exposure to locally formed acetaldehyde via
the saliva without ethanol ingestion.
Methods: The ALDH2 genotypes of 17 subjects were determined by PCR-RFLP. The subjects rinsed out their
mouths with 5 ml of 40 vol% alcohol for 5 seconds. Salivary ethanol and acetaldehyde levels were measured by gas
chromatography.
Results: Acetaldehyde reached mutagenic levels rapidly and the exposure continued for up to 20 minutes. The
mean salivary acetaldehyde concentrations did not differ between ALDH2 genotypes.
Conclusions: For ALDH2 deficient subjects, an elevated exposure to endogenously formed acetaldehyde requires
the presence of ethanol in the systemic circulation.
Impact: Our findings provide a logical explanation for how there is an increased incidence of upper digestive tract
cancers among ALDH2 deficient alcohol drinkers, but not among those ALDH2 deficient subjects who are locally
exposed to acetaldehyde without bloodborne ethanol being delivered to the saliva. Thus, ALDH2 deficient alcohol
drinkers provide a human model for increased local exposure to acetaldehyde derived from the salivary glands.
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Introduction
Cancers of the upper digestive tract are often found at an
advanced stage, remain difficult to treat and have a high
mortality rate. The risk for upper digestive tract cancer for
alcoholics who have an impaired ability to eliminate
acetaldehyde due to a single point mutation in the
mitochondrial aldehyde dehydrogenase 2 (ALDH2) gene is 10-
fold that for alcoholics without the mutation [1,2]. The
substantially increased risk of esophageal squamous cell
carcinoma (ESCC) for ALDH2 deficient alcoholics has provided
the most persuasive evidence for the carcinogenic potential of
acetaldehyde in humans [3-10].
ALDH2 is a low Km mitochondrial enzyme that oxidizes
acetaldehyde to acetate. Approximately 30-50 percent of
Eastern Asians carry an allele (ALDH2*2) of the ALDH2 gene,
which contains a single nucleotide polymorphism (SNP) and
results in the synthesis of an inactive ALDH2 enzyme [11]. In
addition to an increased risk of upper digestive tract cancer,
ALDH2 deficiency is also associated with an increased
exposure of the upper digestive tract mucosa to salivary
acetaldehyde from drinking alcohol [12-14]. Uniform interaction
between ALDH2*2 genotype, alcohol consumption and upper
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digestive tract cancer risk found in epidemiological data and
the elevated local acetaldehyde exposure of ALDH2*2 carriers
who consume alcohol provide convincing evidence for the
specific carcinogenic potential of acetaldehyde in the
pathogenesis of upper digestive tract cancers. Based on these
findings, the International Agency for Research on Cancer
(IARC) recently classified acetaldehyde associated with
alcoholic beverages i.e. present in alcoholic beverages and/or
formed endogenously from ethanol to be a Group 1 carcinogen
in humans [15].
In addition to alcohol consumption, smoking is also a
generally accepted major etiological factor for upper digestive
tract cancers [16]. The multiplicative and dose-dependent
effects of alcohol and tobacco on ESCC risk have been known
for decades and confirmed in studies and meta-analyses
[17,18]. However, it was recently shown that the risk of ESCC
for non-drinking ALDH2 deficient smokers was not higher than
that for non-drinking smokers with functional ALDH2 enzyme
[8].
Unlike the case for alcohol ingestion, in which the ALDH2
genotype significantly potentiates the risk of upper digestive
tract cancer, there seems to be no apparent increased ESCC
risk with ALDH2 deficient non-drinkers [7,19]. Nevertheless,
they may use edibles that contain low amounts of acetaldehyde
or ethanol, e.g. pickled food [20]. This suggests that the
amounts of acetaldehyde formed locally in the oral cavity from
ethanol or delivered to saliva either from tobacco smoke or
food may be independent of the ALDH2 genotype and raises
the question about whether the ALDH2 genotype only has an
effect when systemic ethanol is available.
Our present study follows up on our earlier paper in which 7
ALDH2 deficient individuals and 13 individuals with the
functional ALDH2 enzyme ingested 0.5 g/kg of ethanol and
their salivary acetaldehyde levels were followed thereafter at
20 minute intervals for a period of 240 minutes [12]. At each
time point, salivary acetaldehyde concentrations of ALDH2
deficient individuals were two to three times higher than those
of individuals with the functional ALDH2 enzyme (p<001). In
the present study, our objective was to examine the effect of
the ALDH2 genotype on the exposure of the upper digestive
tract to salivary acetaldehyde when ethanol is only rinsed in the
mouth, but not ingested.
Materials and Methods
Study subjects
20 healthy Eastern Asian volunteers (10 female, 10 male)
were recruited into the study. The mean age of the participants
was 25.7 years (range: 21-38 years) and the mean body mass
index (BMI) 20.9 (range: 18.0-27.8). All the participants were of
Chinese origin and moderate alcohol drinkers i.e. they
consumed <20 drinks/week (men) or <14 drinks/week
(women). Half of the volunteers reported having a history of
alcohol-related flushing symptoms, which are known to
correlate significantly with the ALDH2*2 genotype [21].
Exclusion criteria were pregnancy and use of antimicrobial
medication within 30 days prior to the study visit. The results of
three participants were omitted from the study: in two cases
genotypes could not be analyzed and the third participant was
omitted because of insufficient salivary secretion for analysis.
Ethics Statement
The study was approved by the co-ordinating Ethics
Committee, Hospital District of Helsinki and Uusimaa (Finland).
Signed informed consent to participate in the study was
obtained from each study participant.
Study design
The participants were instructed to abstain from drinking
alcohol for 24 hours before the study visit day and to fast for
two hours before giving samples. Smoking was prohibited on
the day of the study. Salivary samples which were used for
genotyping were collected prior to the ethanol rinsing
experiment. For the rinsing procedure the volunteers gave a
baseline salivary sample and then rinsed their mouths with 5 ml
of 40 vol% alcohol for 5 seconds, after which the oral contents
were discharged and salivary samples were collected at 30 s, 2
min, 5 min, 10 min, 15 min and 20 min after discharging. The
participants also answered a questionnaire regarding their oral
health, alcohol use, smoking, diet and medication.
Genotyping
The genotyping protocol used was modified from Hayashida
et al. [22]. Whole saliva was collected from each participant
and stored at -20°C until analysis. The samples were analyzed
using direct polymerase chain reaction restriction fragment
length polymorphism (PCR-RFLP) on a Mastercycler Gradient
(Eppendorf) to identify a SNP of the ALDH2 gene (rs671). The
PCR protocol included one cycle of 95°C for 5 min, 40 cycles of
98°C for 10 s, 60°C for 30 s, and 74°C for 45 s and a final cycle
of 74°C for 2 min. A 430-bp DNA fragment that contained the
polymorphic site of ALDH2 was amplified by PCR using the
forward primer 5′-TCAAATTACAGGGTCAACTGCT-3′ and the
reverse primer 5′-GGCTGGGTCTTTACCCTCTC-3′ (Sigma-
Aldrich). The PCR reaction required 7.5 µl of distilled water,
12.5 µl of 2X Xtreme Buffer, 2.5 µl of 2 mM
deoxyribonucleotide triphosphates, 10 pmol each for the two
ALDH2 primers, and 0.5 U of KOD Xtreme DNA polymerase (1
U/µl, KOD Xtreme Hot Start DNA Polymerase, Novagen) in a
total volume of 25 µl. PCR products were digested using AcuI
according to the manufacturer’s instructions (New England
Biolabs Inc.). The 430 bp ALDH2*1 fragment was cut into two
fragments of 296 and 134 bp. The ALDH2*2 allele (2*/2*) was
not cut. Fragments were analyzed by using gel electrophoresis
on a 2% agarose gel. Samples of five randomly selected
participants were analyzed twice to assess the reliability of the
genotyping protocol.
Measurement of salivary acetaldehyde and ethanol
50 µl of 6 M perchloric acid was added to 450 µl of saliva to
stop organic reactions, after which the samples were
immediately sealed in 20 ml vials and stored at -20°C until
analysis. Dual or triple parallel samples were collected at each
time point whenever possible to confirm analytical reliability.
Acetaldehyde and ethanol concentrations were measured by
Effect of ALDH2 Genotype on Salivary Acetaldehyde
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headspace gas chromatography as previously described [23].
100 µM acetaldehyde samples were processed with each
batch of study samples as controls.
Statistical analysis
Target sample size (6) was calculated for an effect size of
1.5 SD with an alpha level of 0.05 and a power of 0.80 using
data from our previous study with ALDH2 deficient subjects
[12]. Interactions between different genotypes and salivary
acetaldehyde concentration were estimated by using repeated
measures ANOVA with Huynh-Feldt corrections. The means of
the samples were compared using the Mann-Whitney U test.
The means of parallel duplicate and triplicate samples were
used when determining acetaldehyde concentrations. Group
means were used when calculations included a missing data
point. All calculations were made by using SPSS 15.0.1 (SPSS
Inc., Chicago, IL) statistical software.
Results
Health questionnaire
All of the participants reported brushing their teeth at least
twice per day, three participants (15%) also used
mouthwashes. Nine participants (45%) were smokers and all
reported consuming <20 alcohol drinks/week (men) or <14
alcohol drinks/week (women). Of participants with the ALDH2*2
genotype, four (67%) were smokers. Of the participants without
the ALDH2*2 genotype, four (36%) were smokers. The
genotyping of one smoker was unsuccessful. No chronic
illnesses were reported. Aside from one participant using oral
medication for birth control, no regular medications were
reported. Antibiotics had not been used for at least 30 days.
Two participants (10%) reported following a non-lactose diet.
One participant (5%) followed a vegetarian diet. Only one
participant (5%) reported consuming products that contain
lactic acid bacteria.
Genotyping
Eleven participants carried the ALDH2*1/*1 genotype, five
the ALDH2*1/*2 genotype and one participant the ALDH2*2/*2
genotype (Figure 1). The samples of two participants could not
be analyzed. One other participant produced insufficient saliva
for acetaldehyde analysis and was not also genotyped. The
results of five randomly selected samples were analyzed as a
replicate for reliability assurance and subsequently matched
with the original analyses.
Salivary acetaldehyde concentration
After the 5 s of oral exposure to 40 vol% alcohol, salivary
acetaldehyde concentrations rose quickly and peaked at 2 min
(Figure 2, Table 1). Detectable amounts of acetaldehyde were
found for up to 20 min after the ethanol exposure. A
comparison between subjects with the active ALDH2*1 allele
(ALDH2*1/*1, n=11) and those with the deficient ALDH2*2
allele (ALDH2*1/*2, n=5 and ALDH2*2/*2, n=1) found that there
were no statistically significant differences in the mean in vivo
acetaldehyde levels of the saliva samples for any of the time
points (Table 1, Figure 2). The interactions between different
ALDH2 genotypes and salivary acetaldehyde concentration
were not statistically significant (F=1.482, p=0.237). Also,
analysis of the area under the curve didn’t show a statistically
significant difference between the genotype groups (Mann-
Whitney U 48, p=0.149). There were no statistically significant
differences in levels of salivary acetaldehyde between male
and female subjects or between ALDH2 genotype variants.
Also, the interaction between smoking and salivary
acetaldehyde concentration was not statistically significant
(F=0.562, p=0.620).
Salivary ethanol concentration
Measured ethanol levels peaked at 30 s and thereafter
declined rapidly (Table 2). Detectable amounts of ethanol were
found for up to 20 min after initial exposure. A comparison
between subjects with the active ALDH2*1 allele (ALDH2*1/*1,
n=11) and those with the deficient ALDH2*2 allele
Figure 1.  Gel electrophoresis of digested ALDH2 fragments.  Lane 21 is a positive PCR control, lane 20 is a negative control.
Lanes 2, 4-6, 13, 16 and 19 are ALDH2*1/*2. Lanes 1, 3, 7-12, 14-15 and 17 are ALDH2*1/*1. Lane 18 is unspecified.
doi: 10.1371/journal.pone.0074418.g001
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(ALDH2*1/*2, n=5 and ALDH2*2/*2, n=1) found that there were
no statistically significant differences in the mean in vivo
ethanol levels of the saliva samples for any of the time points
(Table 2). The interactions between different ALDH2 genotypes
and salivary ethanol concentration were not statistically
Table 1. Mean salivary acetaldehyde concentration
according to genotype group (μM ± SD).
Timepoint ALDH2*1 (n=11) ALDH2*2 (n=6) Mann-Whitney U-test P
0.5 min 54.3 ± 21.0 52.3 ± 17.6 31 0.89
2 min 109.5 ± 38.5 145.8 ± 47.2 14 0.06
5 min 69.2 ± 52.9 87.9 ± 22.6 16 0.10
10 min 32.7 ± 24.5 33.9 ± 18.0 27 0.59
15 min 6.8 ± 6.6 13.3 ± 7.6 18 0.15
20 min 3.3 ± 2.5 7.8 ± 6.1 17 0.10
doi: 10.1371/journal.pone.0074418.t001
significant (F=1.133, p=0.316). There were no statistically
significant differences in levels of salivary ethanol between
male and female subjects or between ALDH2 genotype
variants. Also, the interaction between smoking and salivary
ethanol concentration was not statistically significant (F=1.534,
p=0.237).
Discussion
We have earlier demonstrated that after an oral ingestion of
a moderate dose (0.5 g/kg) of ethanol, salivary acetaldehyde
levels measured at 20 minute intervals are 2-3 times higher
among ALDH2 deficient individuals (n = 7) than in those with
functional ALDH2 enzyme (n = 13) [12]. In that study, a
statistically highly significant (p<0.001) difference lasted for 4
hours without overlapping SEM values at any time point. The
association between ingested ethanol and an elevated
Figure 2.  Mean salivary acetaldehyde concentration before and after ethanol exposure according to genotype
group.  ALDH2*1 group: ALDH2*1/*1 (n=11). ALDH2*2 group: ALDH2*1/*2 (n=5) and ALDH2*2/*2 (n=1).
doi: 10.1371/journal.pone.0074418.g002
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concentration of salivary acetaldehyde among ALDH2 deficient
individuals has been confirmed in two later studies [13,14].
Our present results show for the first time that after a brief
oral exposure to non-ingested ethanol, the concentration of
salivary acetaldehyde of ALDH2 deficient subjects is not
significantly higher than that of subjects with normal ALDH2
activity. It should be noted, however, that at the 2 min time
point, means of salivary acetaldehyde between the groups
showed a near-significant difference (p=0.06) which may
become significant should the number of study subjects be
considerably higher. At high concentrations of salivary ethanol
(mean ranging from 248 to 899 mM) that are seen at the 2 and
5 min timepoints, enzymatic activity of the small salivary glands
located in the oral mucosa may also contribute to our findings.
At the 10 and 15 min time points salivary ethanol
concentrations had decreased to 5-30 mM, a level that is
comparable to those found after oral ingestion of alcohol [12].
No measurable levels of acetaldehyde or ethanol were found
from the baseline salivary samples taken before subjects
rinsed their mouths with 40 vol% alcohol. This is in accordance
with earlier findings showing that without the presence of
ethanol or tobacco smoke, normal saliva does not contain
measurable levels of acetaldehyde [23,24]. The rapid rate of
acetaldehyde production at the high initial concentrations of
salivary ethanol can be explained by the presence of high Km
ADH enzymes in the gingiva and the lingual mucosa [25] and
also by the fact that microbial ADH enzymes are not fully
saturated at lower ethanol concentrations [23]. In concordance
with our earlier findings, measurable amounts of ethanol and
acetaldehyde could be found in the saliva for up to 20 min after
rinsing of the mouth with a strong alcohol solution [26].
We used direct PCR in our ALDH2 genotyping protocol in
order to decrease the risk of sample contamination. Our study
did not include the analysis of other genetic factors involved in
ethanol metabolism, such as the ADH1B genotype. This
warrants further studies that should focus on the possible role
of ADH polymorphisms in the exposure of the oral cavity to
ethanol without its ingestion.
Acetaldehyde is widely present in the environment and has
been found to be mutagenic and carcinogenic in vitro and in
animal experiments [27-29]. A recent study demonstrated that
N2-ethylideoxyguanosine adducts, which are mutagenic DNA
adducts previously linked to acetaldehyde exposure, are also
found in the human oral cavity after drinking alcohol [30].
Table 2. Mean salivary ethanol concentration according to
genotype group (mM ± SD).
Timepoint ALDH2*1 (n=11) ALDH2*2 (n=6) Mann-Whitney U-test p
0.5 min 690.1 ± 297.5 899.6 ± 508.3 27 0.59
2 min 248.1 ± 117.7 341.4 ± 185.5 25 0.46
5 min 82.0 ± 54.6 124.0 ± 82.4 22 0.30
10 min 25.1 ± 24.6 28.6 ± 20.3 32 0.96
15 min 4.5 ± 6.2 6.8 ± 5.1 28 0.66
20 min 1.1 ± 1.6 2.6 ± 2.8 24 0.39
doi: 10.1371/journal.pone.0074418.t002
Acetaldehyde in concentrations of 100 µM and above has
been shown to result in an exponential increase in mutagenic
DNA lesions [31]. Acetaldehyde levels of this magnitude can be
found in saliva both during and after an alcohol challenge in
addition to during active tobacco smoking [23,24,26]. For
individuals who have normal ALDH2 activity, this is by and
large due to the bacteria and yeasts present in normal oral
microflora that are able to oxidize ethanol to acetaldehyde, but
their capacity to further oxidize acetaldehyde to acetate is
limited [13,23,32-34]. Thus, the presence of ethanol in saliva
leads to the accumulation of salivary acetaldehyde in
mutagenic concentrations both in vitro and in vivo. The lack of
low Km ALDH enzymes and the presence of high Km ADH
enzymes in the gingiva and the lingual mucosa may further
increase the local exposure to carcinogenic concentrations of
salivary acetaldehyde [25].
The official criterion for alcoholic beverages is that they
contain 2.8 vol% or more of alcohol and their consumption is
systematically followed and used in cancer epidemiology.
However, many non-alcoholic beverages and edibles produced
by fermentation processes may contain low but significant
levels of ethanol in addition to mutagenic concentrations of
acetaldehyde [20,35,36]. Thus, consumption of these products
has been suggested to cumulatively increase the exposure of
the upper digestive tract to carcinogenic acetaldehyde
[35,37-39]. This hypothesis is supported by epidemiological
findings indicating that use of pickled food is a significant risk
factor of esophageal and stomach cancer especially in East
Asian countries [40,41]. Furthermore, positive H. pylori status
combined with high consumption of pickled food has recently
been shown to result in a 27-fold risk of noncardia gastric
cancer [42]. Thus fermented foods and beverages, potential
sources for local acetaldehyde exposure in the upper digestive
tract, constitute a confounding factor that so far has not been
widely considered in cancer epidemiology.
When combined, these results imply that the presence of
ethanol in the systemic circulation is a key factor for the
increased exposure of the upper digestive tract mucosa to
endogenously formed acetaldehyde encountered with ALDH2
deficient consumers of alcohol. Likewise, these findings
provide a logical explanation for the epidemiological findings
that show that ALDH2 deficiency increases the risk of upper
digestive tract cancer for alcohol drinkers, but not for non-
drinkers who are exposed to acetaldehyde that is derived from
sources that do not associate with the presence of ethanol in
the systemic blood circulation [8,19]. Such sources of
exogenous acetaldehyde can be food or tobacco smoke
[20,24].
In conclusion, our present study supports earlier findings that
show that the elevated levels of carcinogenic acetaldehyde
found in the saliva of ALDH2 deficient individuals appear to be
derived from the parotid glands [12,13], which produce
acetaldehyde from systemic ethanol but are unable to detoxify
it. ALDH2 deficiency does not increase salivary acetaldehyde
levels, unless systemic ethanol is available. This finding helps
to explain why the risk of upper digestive tract cancer is only
increased for alcohol consuming ALDH2*2 carriers, but not for
ALDH2 deficient non-drinkers and rare drinkers, regardless of
Effect of ALDH2 Genotype on Salivary Acetaldehyde
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their smoking status and possible consumption of edibles that
contain ethanol or acetaldehyde. Thus, ALDH2 deficient
alcohol drinkers provide a human model for increased local
exposure to acetaldehyde derived from the salivary glands
every time when they are drinking alcoholic beverages.
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